Fiona Burns Selected Research

Cyclophosphamide (Cytoxan)

5/2015

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fiona Burns Research Topics

Disease

7	Infections 04/2024 - 05/2015
5	COVID-19 01/2024 - 01/2021
2	Coinfection 04/2024 - 01/2023
2	Acquired Immunodeficiency Syndrome (AIDS) 04/2021 - 10/2016
1	Persistent Infection 01/2024
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2024
1	Asymptomatic Diseases 01/2023
1	Proteinuria 03/2022
1	Albuminuria 03/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2022
1	Human Influenza (Influenza) 01/2022
1	Myalgia 01/2022
1	Pain (Aches) 01/2022
1	Fatigue 01/2022
1	Inflammation (Inflammations) 01/2022
1	Medically Unexplained Symptoms 10/2021
1	Communicable Diseases (Infectious Diseases) 04/2021
1	Disease Progression 01/2021
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 01/2017
1	Binge Drinking 01/2017
1	Overweight 10/2016
1	Diarrhea 05/2015
1	Mucositis 05/2015
1	Tumor Lysis Syndrome 05/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 05/2015
1	Lymphoma (Lymphomas) 03/2014

Drug/Important Bio-Agent (IBA)

3	NVX-CoV2373 adjuvated lipid nanoparticleIBA 01/2023 - 01/2021
3	VaccinesIBA 01/2023 - 01/2021
2	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2023
2	RNA (Ribonucleic Acid)IBA 01/2024 - 01/2023
2	Immunoglobulin G (IgG)IBA 01/2023 - 01/2022
2	AlbuminsIBA 03/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 03/2022 - 01/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 04/2024
1	ChemokinesIBA 04/2024
1	CytokinesIBA 04/2024
1	Interleukin-15 (Interleukin 15)IBA 01/2024
1	NK Cell Lectin-Like Receptor Subfamily CIBA 01/2024
1	Recombinant ProteinsIBA 01/2023
1	Nucleocapsid ProteinsIBA 01/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2023
1	2019-nCoV Vaccine mRNA-1273IBA 01/2023
1	CreatinineIBA 03/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2022
1	NucleotidesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Saline SolutionIBA 01/2022
1	VS 215IBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2017
1	ORALIT (ORS)IBA 01/2017
1	CholesterolIBA 10/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2015
1	Vincristine (Oncovin)FDA LinkGeneric 05/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2015
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2015
1	Etoposide (VP 16)FDA LinkGeneric 05/2015
1	Rituximab (Mabthera)FDA Link 05/2015

Therapy/Procedure

2	Therapeutics 04/2024 - 10/2016
2	Art Therapy 04/2021 - 01/2017
2	Highly Active Antiretroviral Therapy (HAART) 01/2017 - 05/2015
2	Drug Therapy (Chemotherapy) 05/2015 - 03/2014
1	Intramuscular Injections 01/2022
1	Contraindications 01/2022
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 10/2021
1	Length of Stay 01/2021